DURHAM, NC -- (MARKET WIRE) -- May 10, 2007 -- Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that W. Thomas Amick, Chairman and CEO of Aldagen, will be presenting at the Rodman & Renshaw 4th Annual Global Healthcare Conference. During the presentation, Mr. Amick will provide an overview of the company including recent clinical and strategic developments.
